ST
CPRX

Spot Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Spot Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,600
Closed -$22K – 4066
2014
Q3 		$22K Buy
+6,600
New +$17.2K ﹤0.01% 3943

Other funds holding CPRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $5.37B AUM 18.53% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return

Spot Trading's CPRX Position: Q4 2014 in Review

Spot Trading sold out of Catalyst Pharmaceutical (CPRX) in Q4 2014, closing a stake of 7,785 shares — an estimated $26K sold.

Spot Trading first reported a position in CPRX in Q3 2014 and held it in 1 quarter. The position peaked at $26K in Q3 2014. 50 funds tracked by Wall St. Rank hold CPRX as of Q4 2014.

  • Spot Trading reported no remaining Catalyst Pharmaceutical position as of Q4 2014 after selling out during the quarter.
  • Spot Trading sold 7,785 Catalyst Pharmaceutical shares in Q4 2014, an estimated $26K.
  • Spot Trading first reported a position in Catalyst Pharmaceutical in Q3 2014 and held it in 1 quarter.
  • Spot Trading's Catalyst Pharmaceutical position peaked at $26K in Q3 2014.
  • 50 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.